Godfrey and Colleagues Discuss Mifepristone in Light of Upcoming Supreme Court Case
Posted: 5/23/2024 (CSDE Research)
CSDE Affiliate Emily Godfrey (Family Medicine) and colleagues released an article in JAMA Internal Medicine, titled “Primary Care’s Role in Prescribing Mail-Order Mifepristone“. This summer, the U.S. Supreme Court will decide on the case, Alliance for Hippocratic Medicine v US Food and Drug Administration, determining whether to limit the FDA’s approval to allow mifepristone to be delivered by mail-order pharmacies. Godfrey and colleagues summarize research which demonstrates that mifepristone is safe and effective to prescribe directly to mail-order pharmacies in the primary care setting. They discuss current policy around mifepristone and highlight the potential significance of telehealth and primary care for expanding access to reproductive care.